Table 1 Baseline characteristics of the subjects according to TyG quartiles

TyG

7.81 (7.65–7.97)

8.21 (8.09–8.33)

8.55 (8.42–8.68)

9.04 (8.88–9.30)

Gender (male/%)

783/68.1

801/67.7

799/67.5

794/67.9

Age (years)

37.0 (32.0–44.0)

39.0 (34.0–48.0)

41.0 (35.0–51.0)

45.0 (37.0–54.0)

BMI (kg/m²)

21.0 (19.6–22.9)

21.9 (20.2–24.0)

23.0 (21.2–24.7)

23.9 (22.2–25.7)

SBP (mmHg)

113.0 (106.0–122.0)

115.0 (107.0–124.0)

119.0 (111.0–127.0)

122.0 (114.0–128.0)

DBP (mmHg)

72.0 (67.0–78.0)

74.0 (68.0–79.0)

76.0 (70.0–81.0)

78.0 (73.0–83.0)

WC (cm)

73.0 (68.0–79.0)

76.0 (70.0–82.0)

79.0 (72.0–85.0)

82.0 (76.0–88.0)

BUN (μmol/L)

4.97 (4.24–5.75)

4.93 (4.25–5.76)

5.02 (4.18–5.82)

4.97 (4.16–5.82)

Cr (μmol/L)

72.0 (61.0–81.0)

73.0 (62.0–81.0)

73.0 (61.0–82.0)

72.0 (61.0–81.0)

FPG (mmol/L)

4.25 (3.99–4.51)

4.39 (4.12–4.67)

4.48 (4.20–4.81)

4.67 (4.34–5.09)

UA (μmol/L)

305.0 (251.0–352.0)

311.0 (253.0–367.0)

333.0 (269.0–392.0)

351.0 (286.0–402.0)

AST (U/L)

18.0 (16.0–22.0)

19.0 (16.0–23.0)

20.0 (17.0–24.0)

21.0 (18.0–26.0)

ALT (U/L)

18.0 (14.0–25.0)

20.0 (15.0–30.0)

24.0 (17.0–36.0)

28.0 (20.0–42.0)

γ-GGT (U/L)

14.0 (11.0–20.0)

16.0 (12.0–23.0)

19.0 (13.0–31.0)

25.0 (16.0–41.0)

TC (mmol/L)

4.28 (3.78–4.80)

4.58 (4.07–5.11)

4.78 (4.21–5.35)

5.12 (4.54–5.78)

TG (mmol/L)

0.73 (0.61–0.85)

1.05 (0.90–1.20)

1.44 (1.21–1.67)

2.28 (1.87–2.92)

HDL-C (mmol/L)

1.36 (1.11–1.67)

1.29 (1.08–1.59)

1.22 (1.05–1.50)

1.22 (1.071.45)

LDL-C (mmol/L)

2.27 (1.90–2.68)

2.56 (2.10–3.05)

2.73 (2.26–3.26)

2.89 (2.39–3.46)

Apo-A1(g/L)

1.33 (1.17–1.49)

1.31 (1.14–1.49)

1.28 (1.11–1.49)

1.27 (1.10–1.47)

Apo-B(g/L)

0.77 (0.64–0.90)

0.86 (0.73–1.00)

0.95 (0.81–1.10)

1.06 (0.89–1.23)

eGFR (mL/(min·1.73 m²))

112.2 (99.8–127.1)

109.9 (99.1–123.4)

109.0 (97.1–123.7)

108.9 (96.3–123.5)